From the results of recent randomized controlled clinical trials of disease modifying antirheumatic drugs (DMARDs), slowing radiographic progression has been documented with the use of methotrexate, leflunomide, salazusulfapyridine, IM gold, and cyclosporine. Although the effects of DMARDs is inferior to that of anti-tumor necrosis factor (TNF) agents, DMARDs can stop the progression of joint damage with the achievement of remission or good response.
Download full-text PDF |
Source |
|---|
Publication Analysis
Top Keywords
radiographic progression
8
[inhibition radiographic
4
progression rheumatoid
4
rheumatoid arthritis
4
arthritis anti-rheumatic
4
anti-rheumatic drugs
4
drugs dmards]
4
dmards] randomized
4
randomized controlled
4
controlled clinical
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!